Donate now | Be a volunteer | Contact Us

Let’s walk toward a treatment

Spastic paraplegia : Financing, research, treatment

Spastic Paraplegia causes a degeneration of the central nervous system that can lead to a complete paralysis of the legs.

This genetic disease causes a reduction in the efficiency of the brain signals to be transmitted to the spinal cord. This outcome is revealed by progressive stiffness and weakness of the lower limbs characterized by gait disturbance. The spastic paraplegia progression varies from one individual to another.

Symptoms usually appear between 20 and 40 years of age, but can sometimes start early during childhood.

Currently, there is no known treatment available to prevent, stop or reverse the symptoms of spastic paraplegia.

Learn More

Spastic paraplegia

1% Donated/$493,000 To Go

Help us reach our 500 000$ goal.

To support us, make a donation or join our fundraising activities. Sign up for our newsletter to know about our upcoming events.

Research and treatment

How your donations are used?

All the money raised through our activities are given to the teams of Dr. Guy A. Rouleau to carry out research for the discovery of a treatment against spastic paraplegia (SPG4).

Dr. Guy A. Rouleau is a professor at the Faculty of medicine at McGill University. In addition to his research laboratory, he is in charge of the Neurological Institute and Hospital in Montreal as well as the Department of neurology and neurosurgery at McGill. He also leads a pan-Canadian consortium dedicated to spastic paraplegia research, with the aim of finding effective treatments.

What's New?

Subscribe To Newsletter

Stay informed on new causes and up-coming organization updates. Don’t miss things!

Our Partners